Simulation for population analysis of Michaelis-Menten elimination kinetics

被引:4
|
作者
Hashimoto, Y
Koue, T
Otsuki, Y
Yasuhara, M
Hori, R
Inui, K
机构
[1] KYOTO UNIV HOSP,FAC MED,DEPT PHARM,SAKYO KU,KYOTO 606,JAPAN
[2] KINKI UNIV,PHARMACEUT RES & TECHNOL INST,OSAKA,OSAKA 577,JAPAN
来源
关键词
Michaelis-Menten kinetics; NONMEM; population pharmacokinetics; statistical simulation;
D O I
10.1007/BF02354272
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A simulation study was conducted to compare the cost and performance of various models for population analysis of the steady state pharmacokinetic data arising from a non-compartment model with Michaelis-Menten elimination. The usual Michaelis-Menten model (MM) and its variants provide no estimate of the volume of distribution, and generally give poor estimates of the maximal elimination rate and the Michaelis-Menten constant. The exact solution to the Michaelis-Menten differential equation (TRUE) requires a precise analysis method designed for estimation of population pharmacokinetic parameters (the first-order conditional estimation method) and also considerable computational time to estimate population mean parameters accurately. The one-compartment model with dose-dependent clearance (DDCL). In conjunction with the first-order conditional estimation or Laplacian method, ran approximately 20-fold faster than TRUE and gave accurate population mean parameters for a drug having a long biological half-life relative to the dosing interval. These findings suggest that the well-known MM and its variants should be used carefully for the analysis of blood concentrations of a drug with Michaelis-Menten elimination kinetics, and that TRUE, in conjunction with a precise analysis method, should be considered for estimating population pharmacokinetic parameters. in addition, DDCL is a promising alternative to TRUE with respect to computation time, when the dosing interval is short relative to the biological half-life of a drug.
引用
收藏
页码:205 / 216
页数:12
相关论文
共 50 条
  • [21] EFFECT OF SLEEP ON MICHAELIS-MENTEN ELIMINATION OF ETHANOL
    ROSSI, L
    MADSEN, BW
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1979, 6 (06) : 657 - 657
  • [22] THEORETICAL CONSIDERATIONS IN THE CALCULATION OF BIOAVAILABILITY OF DRUGS EXHIBITING MICHAELIS-MENTEN ELIMINATION KINETICS
    RUBIN, GM
    TOZER, TN
    [J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1984, 12 (04): : 437 - 450
  • [23] TIME CORRECTION FOR COMPUTING MICHAELIS-MENTEN KINETICS
    RODRIGUEZ, F
    PRATS, M
    [J]. COMPUTER APPLICATIONS IN THE BIOSCIENCES, 1992, 8 (06): : 575 - 577
  • [24] MENTEN OF THE MICHAELIS-MENTEN EQUATION
    SMITH, DB
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 1979, 4 (07) : N150 - N150
  • [25] Michaelis-Menten kinetics at high enzyme concentrations
    Tzafriri, AR
    [J]. BULLETIN OF MATHEMATICAL BIOLOGY, 2003, 65 (06) : 1111 - 1129
  • [26] ANALYSIS OF IMMOBILIZED MULTIENZYME REACTION SYSTEMS WITH MICHAELIS-MENTEN KINETICS
    RAMACHANDRAN, PA
    KRISHNA, R
    PANCHAL, CB
    [J]. JOURNAL OF APPLIED CHEMISTRY AND BIOTECHNOLOGY, 1976, 26 (04): : 214 - 224
  • [27] DEVIATION FROM MICHAELIS-MENTEN KINETICS FOR FUMARASE
    CRABBE, MJC
    BARDSLEY, WG
    [J]. BIOCHEMICAL JOURNAL, 1976, 157 (02) : 333 - 337
  • [28] Extensions to Michaelis-Menten Kinetics for Single Parameters
    Ariyawansha, R. T. K.
    Basnayake, B. F. A.
    Karunarathna, A. K.
    Mowjood, M. I. M.
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [29] MICHAELIS-MENTEN KINETICS OF STIRIPENTOL IN NORMAL HUMANS
    LEVY, RH
    LOISEAU, P
    GUYOT, M
    BLEHAUT, HM
    TOR, J
    MORELAND, TA
    [J]. EPILEPSIA, 1984, 25 (04) : 486 - 491
  • [30] Michaelis-Menten kinetics at high enzyme concentrations
    A. R. Tzafriri
    [J]. Bulletin of Mathematical Biology, 2003, 65 : 1111 - 1129